Fundstrat Granny Shots US Small- & Mid-Cap ETF
GRNJ - ETF AI Analysis
Top Page
Fundstrat Granny Shots US Small- & Mid-Cap ETF (GRNJ)
GRNJ’s rating suggests it is a reasonably solid small- and mid-cap ETF, supported by strong contributors like Sanmina and Vicor, which show robust financial performance, positive earnings sentiment, and healthy technical trends. However, several holdings such as Talen Energy and Lumentum face financial and valuation challenges, and the fund’s focus on smaller, growth-oriented companies means investors should be aware of higher volatility and valuation risk. Overall, the mix of strong growth stories and weaker, more speculative names leads to a balanced but not top-tier rating.
GRNJ vs. SPDR S&P 500 ETF (SPY)
- AUM
- 412.25M
- Region
- North America
- Expense Ratio
- 0.75%
- Beta
- 1.75
- Issuer
- Fundstrat
- Inception Date
- Nov 18, 2025
- Dividend Yield
- N/A
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
GRNJ Summary
GRNJ is the Fundstrat Granny Shots US Small- & Mid-Cap ETF, focusing on smaller and mid-sized U.S. companies that may have more room to grow than big, well-known firms. It doesn’t track a fixed index; instead, experts actively pick 20–100 stocks across themes they believe will shape the economy, with a strong tilt toward technology and industrials. Holdings include names like Bloom Energy and Lumentum Holdings. Investors might consider GRNJ for growth potential and diversification beyond large caps. However, small- and mid-cap stocks can be more volatile, so the ETF’s value can move up and down sharply with the market.
How much will it cost me?
The GRNJ ETF has an expense ratio of 0.75%, which means you’ll pay $7.50 per year for every $1,000 invested. This is higher than the average for ETFs because it is actively managed, requiring more research and expertise to select investments.
What would affect this ETF?
GRNJ could benefit from growth in the U.S. small- and mid-cap sectors, especially in industries like Industrials and Technology, which make up a significant portion of its holdings. Positive economic conditions, increased infrastructure spending, or advancements in technology could drive these sectors forward. However, rising interest rates or economic slowdowns could negatively impact smaller companies, as they often face higher borrowing costs and are more sensitive to market downturns.
GRNJ Top 10 Holdings
GRNJ is leaning into a mix of fast-growing niche players, with U.S. small- and mid-cap names doing most of the heavy lifting. SharkNinja and Exelixis are rising and look like key engines for recent gains, while HF Sinclair’s strong run adds a cyclical kick from the energy patch. On the softer side, Natera and Halozyme are more mixed, with recent weakness in health care tempering their longer-term momentum. Echostar and Somnigroup are lagging, acting as small speed bumps. Overall, the fund is U.S.-only and tilted toward tech, industrials, and health care themes.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 EXEL | Exelixis | 2.46% | $10.04M | $17.22B | 64.51% | 78Outperform |
 SN | SharkNinja, Inc. | 2.37% | $9.69M | $31.92B | 146.18% | 76Outperform |
 HALO | Halozyme | 1.82% | $7.44M | $11.74B | 44.99% | 73Outperform |
 NXT | Nextpower Inc | 2.14% | $8.74M | $15.03B | -4.95% | 78Outperform |
 NTRA | Natera | 1.79% | $7.31M | $45.24B | 54.71% | 73Outperform |
 ZETA | Zeta Global Holdings Corp | 2.38% | $9.70M | $8.80B | 90.61% | 67Neutral |
 ECHO | Echostar | 2.30% | $9.41M | $30.31B | 43.38% | 57Neutral |
 SGI | Somnigroup International | 1.82% | $7.44M | $14.46B | -32.12% | 72Outperform |
 DINO | HF Sinclair Corporation | 1.98% | $8.09M | $16.92B | 84.90% | 68Neutral |
 RGLD | Royal Gold | 2.06% | $8.39M | $23.21B | 43.49% | 78Outperform |
GRNJ Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GRNJ, the sentiment is Negative. The current price of 25.85 is below the 20-day moving average (MA) of 26.05, below the 50-day MA of 28.00, and below the 200-day MA of 28.62, indicating a bearish trend. The MACD of -0.93 indicates Negative momentum. The RSI at 45.81 is Neutral, neither overbought nor oversold. The STOCH value of 59.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GRNJ.
GRNJ Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| GRNJ | $25.85 | $32.00(23.79% Upside) | $412.25M | 0.75% | 69Neutral |
 RSMC | $28.23 | $33.89(20.02% Upside) | $740.87M | 0.75% | 68Neutral |
 MSSM | $59.08 | $71.87(21.65% Upside) | $705.72M | 0.62% | 64Neutral |
 ASCE | $33.18 | $41.37(24.69% Upside) | $385.90M | 0.38% | 71Outperform |
 SMIZ | $40.91 | $47.82(16.89% Upside) | $271.88M | 0.55% | 68Neutral |
 RNIN | $38.62 | $44.34(14.81% Upside) | $212.72M | 0.68% | 69Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GRNJ | Fundstrat Granny Shots US Small- & Mid-Cap ETF | 25.85 | 1.55 | 6.38% | |
| RSMC | Rockefeller U.S. Small-Mid Cap ETF | 28.23 | 2.95 | 11.69% | |
| MSSM | Morgan Stanley Pathway Small-Mid Cap Equity ETF | 59.08 | 10.39 | 21.35% | |
| ASCE | Allspring SMID Core ETF | 33.18 | 7.68 | 30.14% | |
| SMIZ | Zacks Small/Mid Cap ETF | 40.91 | 4.63 | 12.76% | |
| RNIN | Bushido Capital US SMID Cap Equity ETF | 38.62 | 11.81 | 44.07% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.